why choose us

First received: August 19, 2022

Clinical Trial: Reduced-dose Botox for Urgency Incontinence Among Elder Females

Study Status: Completed

Recruit Status: RECRUITING

Condition: Overactive Bladder

Study Type: INTERVENTIONAL


Official Title: Reduced-dose onabotuLinumtoxinA for Urgency Incontinence Among Elder Females (RELIEF): A Randomized Controlled Comparative Effectiveness Trial With Embedded Qualitative and Costing Analyses

Brief Summary: The purpose of this study is to study the treatment of urgency urinary incontinence (UUI), specifically among women 70 years and older, by comparing reduced versus standard dose of onabotulinumtoxinA (BTX; trade name BOTOX(c)) injection in the bladder.

Read more